Trials / Conditions / Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

16 registered clinical trials studyying Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) — 14 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosino NCT07524127	University Hospital, Montpellier	N/A
Not Yet Recruiting	A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (C NCT07436949	Bambusa Therapeutics	Phase 1 / Phase 2
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With N NCT07313917	Longbio Pharma	Phase 2
Recruiting	ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia NCT07399665	AstraZeneca	—
Not Yet Recruiting	Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From As NCT07134686	Assistance Publique Hopitaux De Marseille	N/A
Not Yet Recruiting	Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP NCT07200336	Eye & ENT Hospital of Fudan University	Phase 4
Not Yet Recruiting	Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhino NCT07046117	Medical University of Vienna	N/A
Recruiting	Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps NCT07107256	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.	Phase 3
Recruiting	Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy NCT07125586	The Affiliated Hospital of Qingdao University	N/A
Active Not Recruiting	International Severe CRSwNP Registry 2024-2028 NCT06617754	Vibeke Backer	—
Not Yet Recruiting	A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps NCT06801353	Beijing Tongren Hospital	Phase 4
Recruiting	A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With NCT06338995	Eli Lilly and Company	Phase 3
Not Yet Recruiting	Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP NCT06231004	The First Affiliated Hospital with Nanjing Medical University	—
Recruiting	Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery NCT06776042	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	N/A
Recruiting	Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) NCT06683261	Universitaire Ziekenhuizen KU Leuven	—
Completed	GB001 in Adult Participants With Chronic Rhinosinusitis NCT03956862	GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.	Phase 2